Get the Stockscreener App
17.40
1.05%
0.18
After Hours:
17.40
Oculis Holding Ag stock is traded at $17.40, with a volume of 11,196.
It is up +1.05% in the last 24 hours and down -3.97% over the past month.
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
See More
Previous Close:
$17.22
Open:
$17.2
24h Volume:
11,196
Relative Volume:
0.73
Market Cap:
$759.73M
Revenue:
-
Net Income/Loss:
$-75.28M
P/E Ratio:
-8.7187
EPS:
-1.9957
Net Cash Flow:
$-57.45M
1W Performance:
+1.05%
1M Performance:
-3.97%
6M Performance:
-7.64%
1Y Performance:
+45.61%
1-Day Range:
$16.94
$17.46
1-Week Range:
$16.94
$17.46
52-Week Range:
$11.78
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
Compare OCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
17.40 | 901.48M | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Initiated | Needham | Buy |
| Dec-05-23 | Initiated | Chardan Capital Markets | Buy |
| Oct-05-23 | Initiated | Stifel | Buy |
| Jun-14-23 | Initiated | BofA Securities | Buy |
| Jun-12-23 | Initiated | H.C. Wainwright | Buy |
| Jun-08-23 | Initiated | Robert W. Baird | Outperform |
| May-10-23 | Initiated | Pareto | Buy |
| Apr-28-23 | Initiated | Wedbush | Outperform |
View All
Oculis Holding Ag Stock (OCS) Latest News
Oculis (NASDAQ:OCS) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Visual analytics tools that track Oculis Holding AG performanceTrade Risk Assessment & Free High Return Stock Watch Alerts - Newser
Is Oculis Holding AG forming a reversal patternProfit Target & Technical Pattern Based Signals - Newser
Automated trading signals detected on Oculis Holding AGTreasury Yields & Safe Capital Growth Tips - Newser
Tools to monitor Oculis Holding AG Equity Warrant recovery probabilityMarket Activity Recap & Verified Swing Trading Watchlists - Newser
Using fundamentals and technicals on Oculis Holding AG Equity Warrant2025 Market Overview & Weekly High Potential Stock Alerts - Newser
How to recover losses in Oculis Holding AG stockQuarterly Portfolio Review & Risk Controlled Daily Plans - Newser
Technical signs of recovery in Oculis Holding AG Equity WarrantGold Moves & Verified Momentum Stock Alerts - Newser
How to monitor Oculis Holding AG with trend dashboardsQuarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
Alyeska Investment Group L.P. Purchases Shares of 131,332 Oculis Holding AG $OCS - MarketBeat
Using Bollinger Bands to evaluate Oculis Holding AGDip Buying & Daily Market Momentum Tracking - Newser
Price momentum metrics for Oculis Holding AG explainedProfit Target & Intraday High Probability Setup Alerts - Newser
Is Oculis Holding AG showing signs of accumulationPrice Action & Stepwise Entry and Exit Trade Signals - Newser
Using Python tools to backtest Oculis Holding AG Equity Warrant strategiesJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
Is Oculis Holding AG Equity Warrant stock bottoming outWeekly Investment Report & Long-Term Safe Return Strategies - Newser
Real time breakdown of Oculis Holding AG Equity Warrant stock performanceForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
How to recover losses in Oculis Holding AG Equity Warrant stock2025 Analyst Calls & Risk Managed Investment Signals - Newser
Will breakout in Oculis Holding AG Equity Warrant lead to full recoveryDip Buying & Short-Term Trading Alerts - Newser
Can Oculis Holding AG Equity Warrant hit a new high this monthMarket Rally & Smart Investment Allocation Tips - Newser
Can trapped investors hope for a rebound in Oculis Holding AGJuly 2025 Movers & Breakout Confirmation Trade Signals - Newser
Oculis Holding AG stock trend forecastJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - Newser
Using Bollinger Bands to evaluate Oculis Holding AG Equity WarrantEarnings Growth Report & Long-Term Growth Portfolio Plans - Newser
What indicators show strength in Oculis Holding AG Equity WarrantWatch List & High Accuracy Investment Entry Signals - Newser
Volatility clustering patterns for Oculis Holding AG Equity WarrantPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser
Using R and stats models for Oculis Holding AG forecastingJuly 2025 Fed Impact & Weekly High Return Opportunities - Newser
Tick level data insight on Oculis Holding AG Equity Warrant volatilityEntry Point & AI Forecasted Entry/Exit Points - Newser
Analyzing drawdowns of Oculis Holding AG Equity Warrant with statistical toolsWeekly Trend Summary & Weekly Watchlist for Consistent Profits - Newser
Executive Stock Awards: Oculis Directors Receive Vested RSUs in Latest Compensation Milestone - Stock Titan
What’s the outlook for Oculis Holding AG’s sectorWeekly Investment Summary & Real-Time Market Sentiment Alerts - Lancaster City Council
Can technical indicators confirm Oculis Holding AG Equity Warrant’s reversalPortfolio Value Summary & Accurate Buy Signal Alerts - Newser
Oculis Holding AG stock daily chart insights2025 Stock Rankings & Low Drawdown Momentum Ideas - Newser
Oculis Holding AG Equity Warrant recovery potential after sell offMarket Activity Summary & Fast Moving Market Watchlists - Newser
What MACD and RSI say about Oculis Holding AG Equity WarrantWeekly Trend Report & Low Risk High Reward Trade Ideas - Newser
Earnings visualization tools for Oculis Holding AGJuly 2025 Movers & Weekly High Return Opportunities - Newser
Order flow analysis tools used on Oculis Holding AGFed Meeting & Weekly High Potential Stock Alerts - Newser
How to build a dashboard for Oculis Holding AG Equity Warrant stockWeekly Stock Analysis & Community Verified Trade Signals - Newser
Oculis Holding AG Equity Warrant stock trend forecastMarket Weekly Review & AI Driven Price Predictions - Newser
Is Oculis Holding AG stock poised for growthInsider Selling & AI Enhanced Trading Alerts - Newser
Can a trend reversal in Oculis Holding AG lead to recoveryWeekly Investment Report & Entry Point Confirmation Signals - Newser
Ranking Oculis Holding AG among high performing stocks via toolsJuly 2025 Fed Impact & Stock Portfolio Risk Management - Newser
Is Oculis Holding AG Equity Warrant benefiting from interest rate changesJuly 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - classian.co.kr
ranking oculis holding ag among high performing stocks via tools2025 Fundamental Recap & Consistent Profit Alerts - Newser
Is this a good reentry point in Oculis Holding AG Equity WarrantQuarterly Portfolio Summary & Smart Swing Trading Alerts - Newser
How institutional ownership impacts Oculis Holding AG stock2025 Growth vs Value & Consistent Income Trade Recommendations - Newser
Custom watchlist performance reports with Oculis Holding AG Equity WarrantChart Signals & Capital Protection Trade Alerts - Newser
Technical Models Suggest Oculis Holding AG May Rebound SoonJuly 2025 Update & Low Risk Growth Stock Ideas - beatles.ru
Oculis (NASDAQ:OCS) Sees Large Volume IncreaseHere's Why - MarketBeat
Can Oculis Holding AG stock outperform in a bear marketJuly 2025 Final Week & Community Supported Trade Ideas - beatles.ru
Using flow based indicators on Oculis Holding AGJuly 2025 Drop Watch & Fast Moving Trade Plans - Newser
Is Oculis Holding AG a top pick in the sectorJuly 2025 Spike Watch & Daily Volume Surge Signals - خودرو بانک
Will Oculis Holding AG stock recover after earnings2025 Year in Review & Fast Gaining Stock Reports - خودرو بانک
Oculis Holding Ag Stock (OCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):